GLOFITAMAB

GLOFITAMAB was reported 2709 times

GLOFITAMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY 4 0.8000
1 HERPETIC RADICULOPATHY 1 0.1250
2 PRIMARY CARDIAC LYMPHOMA 2 0.1250
3 BLOOD TYPE INCOMPATIBILITY 1 0.1250
4 HEPATOBILIARY NEOPLASM 1 0.1000
5 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV 1 0.0833
6 TUMOUR FLARE 56 0.0820
7 CD19 ANTIGEN LOSS 1 0.0625
8 INTERSTITIAL LUNG THICKENING 1 0.0625
9 FACTOR XI DEFICIENCY 1 0.0500
10 T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0500
11 CD19 LYMPHOCYTE COUNT ABNORMAL 1 0.0476
12 DIAPHRAGM NEOPLASM 1 0.0435
13 METASTASES TO MOUTH 1 0.0435
14 CYTOKINE RELEASE SYNDROME 855 0.0426
15 RESPIRATORY TRACT NEOPLASM 1 0.0417
16 COR PULMONALE CHRONIC 7 0.0372
17 SIMPLE MASTECTOMY 1 0.0370
18 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 78 0.0353
19 AORTIC PSEUDOANEURYSM 2 0.0339
20 CONGENITAL APLASIA 9 0.0289
21 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 156 0.0263
22 HAIRY CELL LEUKAEMIA RECURRENT 1 0.0244
23 MANTLE CELL LYMPHOMA 33 0.0217
24 BLOOD LACTATE DEHYDROGENASE DECREASED 7 0.0210
25 PERITUMOURAL OEDEMA 1 0.0208
26 BLOOD CATECHOLAMINES DECREASED 1 0.0196
27 COAGULATION FACTOR XIII LEVEL DECREASED 1 0.0192
28 CATHETER SITE PHLEBITIS 1 0.0192
29 NEOPLASM SWELLING 1 0.0185
30 FOLLICULAR LYMPHOMA 16 0.0182
31 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 17 0.0180
32 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0173
33 MANTLE CELL LYMPHOMA STAGE IV 1 0.0167
34 RENAL HYDROCELE 1 0.0167
35 SUBMANDIBULAR ABSCESS 1 0.0167
36 NECROTIC LYMPHADENOPATHY 2 0.0167
37 URINARY TRACT NEOPLASM 1 0.0161
38 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0158
39 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 5 0.0152
40 LOW DENSITY LIPOPROTEIN 1 0.0147
41 ENCEPHALITIS CYTOMEGALOVIRUS 6 0.0137
42 INFLAMMATORY PSEUDOTUMOUR 1 0.0135
43 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 2 0.0132
44 HYPERAMYLASAEMIA 7 0.0128
45 GENITOURINARY TRACT NEOPLASM 1 0.0120
46 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 1 0.0116
47 TUMOUR OBSTRUCTION 1 0.0115
48 ACCESSORY SPLEEN 1 0.0111
49 B-CELL LYMPHOMA RECURRENT 6 0.0110
50 LEUKODYSTROPHY 1 0.0108
51 SELECTIVE IGG SUBCLASS DEFICIENCY 1 0.0106
52 PARVOVIRUS INFECTION 4 0.0099
53 URETERAL DISORDER 4 0.0097
54 PARAINFLUENZA VIRUS INFECTION 1 0.0097
55 HYPERPYREXIA 39 0.0092
56 INTERLEUKIN LEVEL INCREASED 5 0.0091
57 ACUTE HEPATITIS B 3 0.0090
58 BLOOD ELECTROLYTES INCREASED 1 0.0085
59 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 1 0.0082
60 PLEURAL DISORDER 5 0.0080
61 CD19 LYMPHOCYTES DECREASED 1 0.0077
62 SOFT TISSUE NEOPLASM 1 0.0076
63 LEUKOSTASIS SYNDROME 1 0.0075
64 CYTOMEGALOVIRUS INFECTION REACTIVATION 33 0.0075
65 CYTOKINE INCREASED 1 0.0074
66 BRONCHIAL NEOPLASM 1 0.0074
67 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 1 0.0070
68 DIFFUSE LARGE B-CELL LYMPHOMA 48 0.0062
69 MYOCARDIAL INJURY 7 0.0062
70 SYSTEMIC CANDIDA 15 0.0060
71 GIARDIASIS 2 0.0059
72 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1 0.0057
73 JC VIRUS INFECTION 9 0.0056
74 LIMB IMMOBILISATION 1 0.0054
75 ENTEROBACTER SEPSIS 2 0.0054
76 CEREBELLAR ISCHAEMIA 1 0.0054
77 B-LYMPHOCYTE COUNT INCREASED 1 0.0054
78 HAEMATOPOIETIC NEOPLASM 1 0.0053
79 ANISOCORIA 2 0.0053
80 NEUTROPENIC INFECTION 5 0.0052
81 UREAPLASMA INFECTION 2 0.0049
82 CUTANEOUS LYMPHOMA 1 0.0049
83 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
84 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
85 CLOSTRIDIUM BACTERAEMIA 1 0.0047
86 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
87 MANTLE CELL LYMPHOMA RECURRENT 2 0.0046
88 C-REACTIVE PROTEIN DECREASED 3 0.0046
89 CHRONIC GRAFT VERSUS HOST DISEASE 16 0.0044
90 AORTITIS 3 0.0044
91 PLEURAL INFECTION 1 0.0043
92 HYPOGAMMAGLOBULINAEMIA 28 0.0043
93 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 9 0.0042
94 CREST SYNDROME 1 0.0042
95 JEJUNAL PERFORATION 1 0.0041
96 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
97 TUMOUR INVASION 2 0.0041
98 DISEASE PROGRESSION 486 0.0041
99 DEVICE RELATED THROMBOSIS 4 0.0041
100 INFECTIVE ANEURYSM 2 0.0040
101 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
102 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
103 INFESTATION 1 0.0039
104 GASTROINTESTINAL LYMPHOMA 1 0.0038
105 HERPES ZOSTER REACTIVATION 1 0.0038
106 CYTOTOXIC OEDEMA 1 0.0038
107 INJECTION RELATED REACTION 6 0.0036
108 URETERIC DILATATION 1 0.0036
109 ENTEROCOLITIS BACTERIAL 1 0.0036
110 DUCTAL ADENOCARCINOMA OF PANCREAS 1 0.0036
111 GENITOURINARY TRACT INFECTION 1 0.0035
112 PSEUDOMONAL BACTERAEMIA 3 0.0035
113 CHOROIDAL NEOVASCULARISATION 3 0.0035
114 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
115 TUMOUR LYSIS SYNDROME 30 0.0034
116 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
117 DUODENAL OBSTRUCTION 1 0.0033
118 SUSPECTED OFF LABEL USE 15 0.0033
119 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
120 BILIARY TRACT INFECTION 2 0.0032
121 INTERVERTEBRAL DISCITIS 6 0.0032
122 CHRONIC HEPATITIS B 1 0.0032
123 TUMOUR COMPRESSION 1 0.0031
124 COLORECTAL ADENOMA 1 0.0031
125 TUMOUR PAIN 4 0.0030
126 HYPOFIBRINOGENAEMIA 3 0.0030
127 METASTASES TO BREAST 1 0.0030
128 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
129 SOFT TISSUE INFLAMMATION 1 0.0030
130 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
131 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
132 LIVER FUNCTION TEST DECREASED 1 0.0028
133 GLOBULINS INCREASED 1 0.0027
134 TUMOUR PSEUDOPROGRESSION 3 0.0027
135 BRONCHOPNEUMOPATHY 1 0.0027
136 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
137 GRANULOCYTE COUNT DECREASED 5 0.0027
138 KLEBSIELLA SEPSIS 3 0.0027
139 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
140 PERIPROSTHETIC FRACTURE 1 0.0026
141 HYPOPROTEINAEMIA 5 0.0026
142 SCLERODERMA RENAL CRISIS 1 0.0026
143 HERPES SIMPLEX REACTIVATION 1 0.0026
144 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
145 GASTRIC PERFORATION 7 0.0026
146 BLOOD FIBRINOGEN INCREASED 2 0.0025
147 BONE DENSITY INCREASED 1 0.0025
148 VASCULAR ACCESS COMPLICATION 2 0.0025
149 COVID-19 PNEUMONIA 29 0.0025
150 TUMOUR ASSOCIATED FEVER 1 0.0024
151 SQUAMOUS CELL CARCINOMA OF THE TONGUE 1 0.0024
152 POST-ACUTE COVID-19 SYNDROME 3 0.0024
153 GASTROINTESTINAL CANDIDIASIS 1 0.0024
154 B-CELL LYMPHOMA 8 0.0024
155 ABDOMINAL NEOPLASM 2 0.0022
156 ORGANISING PNEUMONIA 11 0.0022
157 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0021
158 INTRACRANIAL MASS 2 0.0021
159 PNEUMONIA HAEMOPHILUS 1 0.0021
160 METASTASES TO BONE MARROW 1 0.0020
161 MYELOID LEUKAEMIA 1 0.0020
162 SPLENIC VEIN THROMBOSIS 1 0.0020
163 PO2 INCREASED 1 0.0020
164 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
165 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
166 CEREBRAL ARTERY THROMBOSIS 1 0.0019
167 GRAFT VERSUS HOST DISEASE 14 0.0019
168 BACTERIAL INFECTION 36 0.0019
169 VARICELLA ZOSTER VIRUS INFECTION 4 0.0019
170 URETEROLITHIASIS 2 0.0019
171 HEPATITIS E 3 0.0019
172 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
173 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
174 CORYNEBACTERIUM INFECTION 1 0.0019
175 BLOOD GASES ABNORMAL 1 0.0019
176 SCROTAL PAIN 1 0.0019
177 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
178 HEPATORENAL SYNDROME 3 0.0018
179 METASTASES TO MENINGES 4 0.0018
180 VITH NERVE PARALYSIS 2 0.0018
181 BLOOD FIBRINOGEN DECREASED 2 0.0018
182 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
183 IRREGULAR BREATHING 1 0.0017
184 PROCALCITONIN INCREASED 2 0.0017
185 FEBRILE INFECTION 2 0.0017
186 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
187 DIAPHRAGMATIC PARALYSIS 1 0.0017
188 BONE MARROW DISORDER 5 0.0017
189 OXYGEN CONSUMPTION DECREASED 1 0.0017
190 SOFT TISSUE INFECTION 3 0.0016
191 HAEMATOLOGICAL INFECTION 4 0.0016
192 OSTEOMYELITIS CHRONIC 1 0.0016
193 FEBRILE NEUTROPENIA 107 0.0016
194 NECROTISING RETINITIS 1 0.0016
195 AUTOIMMUNE COLITIS 1 0.0016
196 CYTOPENIA 19 0.0016
197 VASCULAR DEVICE INFECTION 7 0.0015
198 PNEUMONIA FUNGAL 6 0.0015
199 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
200 ORGAN FAILURE 6 0.0015
201 CYTOKINE STORM 1 0.0015
202 IMMUNOGLOBULINS DECREASED 2 0.0015
203 NEUTROPENIA 198 0.0015
204 CAPILLARY LEAK SYNDROME 3 0.0014
205 HYPERTRANSAMINASAEMIA 10 0.0014
206 CRANIAL NERVE DISORDER 1 0.0014
207 FUSARIUM INFECTION 1 0.0014
208 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
209 TONGUE PARALYSIS 1 0.0014
210 INVESTIGATION ABNORMAL 2 0.0014
211 VASOGENIC CEREBRAL OEDEMA 1 0.0014
212 COMA HEPATIC 1 0.0013
213 LARGE INTESTINAL OBSTRUCTION 3 0.0013
214 ARTERIAL INJURY 1 0.0013
215 MARASMUS 2 0.0013
216 CYTOMEGALOVIRUS COLITIS 3 0.0013
217 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
218 ACUTE MYELOID LEUKAEMIA 20 0.0013
219 SUPERINFECTION BACTERIAL 1 0.0013
220 HEPATIC CYTOLYSIS 16 0.0013
221 PELVIC MASS 1 0.0012
222 ENTEROCOCCAL SEPSIS 1 0.0012
223 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
224 SEBORRHOEIC DERMATITIS 2 0.0012
225 CAMPYLOBACTER INFECTION 1 0.0012
226 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
227 PYLORIC STENOSIS 1 0.0012
228 DISSEMINATED TUBERCULOSIS 3 0.0012
229 POLYNEUROPATHY 14 0.0012
230 HYPOALBUMINAEMIA 9 0.0012
231 GASTROINTESTINAL NEOPLASM 1 0.0012
232 TRANSFUSION REACTION 1 0.0011
233 NEUTROPENIC SEPSIS 8 0.0011
234 CANDIDA SEPSIS 1 0.0011
235 MYELOSUPPRESSION 40 0.0011
236 BLOOD MAGNESIUM INCREASED 1 0.0011
237 OROPHARYNGEAL CANDIDIASIS 1 0.0011
238 MUSCLE SWELLING 1 0.0011
239 ENTEROCOLITIS INFECTIOUS 1 0.0011
240 C-REACTIVE PROTEIN 1 0.0011
241 HYDRONEPHROSIS 8 0.0011
242 PNEUMONIA CRYPTOCOCCAL 1 0.0011
243 KLEBSIELLA BACTERAEMIA 1 0.0011
244 PYELOCALIECTASIS 1 0.0010
245 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
246 PROSTATE INFECTION 1 0.0010
247 HYPOCOAGULABLE STATE 1 0.0010
248 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
249 HAEMOPHILUS INFECTION 1 0.0010
250 MASTOIDITIS 1 0.0010
251 SPUTUM RETENTION 1 0.0010
252 CELL DEATH 2 0.0010
253 LARGE INTESTINE PERFORATION 7 0.0010
254 SEPTIC SHOCK 43 0.0010
255 BREAST NEOPLASM 1 0.0010
256 METASTASES TO SKIN 1 0.0010
257 ASPARTATE AMINOTRANSFERASE INCREASED 51 0.0010
258 SERUM FERRITIN INCREASED 5 0.0009
259 HYPOPHOSPHATAEMIA 7 0.0009
260 HAEMATOTOXICITY 9 0.0009
261 TUMOUR NECROSIS 1 0.0009
262 ENTEROCOCCAL BACTERAEMIA 1 0.0009
263 PNEUMONIA VIRAL 3 0.0009
264 ORCHITIS 1 0.0009
265 HYPERPHOSPHATAEMIA 2 0.0009
266 HEPATIC LESION 4 0.0009
267 STREPTOCOCCAL BACTERAEMIA 1 0.0009
268 ACARODERMATITIS 1 0.0009
269 ACINETOBACTER INFECTION 1 0.0009
270 INTESTINAL ISCHAEMIA 5 0.0009
271 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
272 VANISHING BILE DUCT SYNDROME 1 0.0009
273 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
274 ADENOCARCINOMA 2 0.0009
275 SARCOMA 1 0.0009
276 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
277 TEMPERATURE INTOLERANCE 9 0.0009
278 NEUROLOGICAL DECOMPENSATION 2 0.0009
279 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
280 THROMBOCYTOPENIA 95 0.0008
281 STREPTOCOCCAL SEPSIS 1 0.0008
282 SECOND PRIMARY MALIGNANCY 7 0.0008
283 PNEUMONIA INFLUENZAL 1 0.0008
284 BONE LESION 3 0.0008
285 BLEEDING TIME PROLONGED 1 0.0008
286 CLOSTRIDIUM COLITIS 1 0.0008
287 SECONDARY IMMUNODEFICIENCY 1 0.0008
288 ENCEPHALITIS VIRAL 1 0.0008
289 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
290 LEUKOENCEPHALOPATHY 3 0.0008
291 INTESTINAL PERFORATION 9 0.0008
292 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
293 LYMPHOCYTE COUNT DECREASED 14 0.0008
294 INFECTION 114 0.0008
295 NEOPLASM 9 0.0008
296 CANCER PAIN 2 0.0008
297 BLOOD BILIRUBIN INCREASED 21 0.0008
298 NEOPLASM PROGRESSION 27 0.0008
299 TRANSITIONAL CELL CARCINOMA 1 0.0008
300 PNEUMONIA BACTERIAL 7 0.0008
301 ENCEPHALITIS AUTOIMMUNE 1 0.0008
302 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
303 ABDOMINAL MASS 2 0.0007
304 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
305 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
306 HYPERCALCAEMIA 9 0.0007
307 COVID-19 126 0.0007
308 LYMPHOMA 11 0.0007
309 INTESTINAL FISTULA 1 0.0007
310 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
311 SINUS TACHYCARDIA 10 0.0007
312 LUNG NEOPLASM 3 0.0007
313 TUMOUR HAEMORRHAGE 2 0.0007
314 POST HERPETIC NEURALGIA 1 0.0007
315 NOROVIRUS INFECTION 1 0.0007
316 BLOOD URIC ACID INCREASED 4 0.0007
317 PULMONARY SEPSIS 1 0.0007
318 SUPERINFECTION 1 0.0007
319 STEROID DIABETES 1 0.0007
320 HEPATITIS B 4 0.0007
321 LUMBAR VERTEBRAL FRACTURE 3 0.0007
322 GENITAL HERPES 1 0.0007
323 PNEUMONIA PSEUDOMONAL 1 0.0007
324 NEOPLASM SKIN 1 0.0006
325 PYREXIA 221 0.0006
326 NEUTROPHIL COUNT DECREASED 26 0.0006
327 FUNGAEMIA 1 0.0006
328 HEPATITIS B REACTIVATION 2 0.0006
329 CYSTITIS INTERSTITIAL 1 0.0006
330 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
331 BACTERIAL SEPSIS 2 0.0006
332 VASOPLEGIA SYNDROME 1 0.0006
333 SHOCK 14 0.0006
334 IMMUNE SYSTEM DISORDER 8 0.0006
335 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
336 SYSTEMIC INFECTION 1 0.0006
337 ANAEMIA 115 0.0006
338 CYTOMEGALOVIRUS INFECTION 10 0.0006
339 CARDIAC FAILURE ACUTE 4 0.0006
340 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
341 SKIN WOUND 1 0.0006
342 TACHYPNOEA 8 0.0006
343 PNEUMONITIS 16 0.0006
344 RETINITIS 1 0.0006
345 VASCULAR PSEUDOANEURYSM 1 0.0006
346 NEUROTOXICITY 10 0.0006
347 METASTASES TO LIVER 10 0.0006
348 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
349 VOCAL CORD PARALYSIS 1 0.0006
350 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
351 DISORGANISED SPEECH 1 0.0005
352 PUPILLARY REFLEX IMPAIRED 1 0.0005
353 FUNGAL INFECTION 18 0.0005
354 CARDIAC DYSFUNCTION 2 0.0005
355 IMMUNODEFICIENCY 8 0.0005
356 MALNUTRITION 6 0.0005
357 SACROILIITIS 1 0.0005
358 GRANULOCYTOPENIA 3 0.0005
359 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
360 ENTEROCOLITIS 3 0.0005
361 TRAUMATIC LUNG INJURY 1 0.0005
362 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
363 RHINOVIRUS INFECTION 2 0.0005
364 THERAPY PARTIAL RESPONDER 8 0.0005
365 BACTERAEMIA 6 0.0005
366 LARGE INTESTINAL STENOSIS 1 0.0005
367 DEVICE RELATED SEPSIS 1 0.0005
368 C-REACTIVE PROTEIN INCREASED 18 0.0005
369 IMMUNE-MEDIATED HEPATITIS 1 0.0005
370 VENOUS THROMBOSIS LIMB 1 0.0005
371 OLIGURIA 3 0.0005
372 HYPERBILIRUBINAEMIA 5 0.0005
373 VIRAL INFECTION 16 0.0005
374 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
375 LEUKOPENIA 24 0.0005
376 PLATELET COUNT DECREASED 51 0.0005
377 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
378 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
379 ENTERITIS 3 0.0005
380 CD4 LYMPHOCYTES DECREASED 1 0.0005
381 LYMPHOCYTOSIS 1 0.0005
382 METASTATIC NEOPLASM 2 0.0005
383 HERPES SIMPLEX 3 0.0005
384 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
385 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
386 SEPSIS 51 0.0005
387 NOSOCOMIAL INFECTION 1 0.0005
388 RESPIRATORY FAILURE 33 0.0005
389 LYMPHADENOPATHY 16 0.0005
390 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
391 HEPATIC FUNCTION ABNORMAL 16 0.0004
392 BILIRUBIN CONJUGATED INCREASED 1 0.0004
393 METASTASES TO BONE 7 0.0004
394 LYMPHOPENIA 6 0.0004
395 URINARY TRACT OBSTRUCTION 1 0.0004
396 MUCOSAL INFLAMMATION 11 0.0004
397 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
398 LACUNAR INFARCTION 1 0.0004
399 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
400 MYELODYSPLASTIC SYNDROME 6 0.0004
401 ENTEROCOCCAL INFECTION 2 0.0004
402 PANCYTOPENIA 23 0.0004
403 BRONCHITIS CHRONIC 1 0.0004
404 GLOMERULONEPHRITIS 1 0.0004
405 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
406 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
407 HYPERVOLAEMIA 2 0.0004
408 INFLAMMATORY MARKER INCREASED 2 0.0004
409 KETOACIDOSIS 3 0.0004
410 HYPERAMMONAEMIA 2 0.0004
411 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
412 DYSPHORIA 2 0.0004
413 HYPERTHERMIA 3 0.0004
414 ABDOMINAL INFECTION 1 0.0004
415 URINARY RETENTION 13 0.0004
416 BLOOD CHLORIDE DECREASED 1 0.0004
417 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
418 MUCORMYCOSIS 1 0.0004
419 MALIGNANT NEOPLASM PROGRESSION 39 0.0004
420 BLOOD LACTIC ACID INCREASED 2 0.0004
421 RADICULOPATHY 1 0.0004
422 THERAPY NON-RESPONDER 17 0.0004
423 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
424 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
425 HYPERLACTACIDAEMIA 1 0.0004
426 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
427 OFF LABEL USE 325 0.0004
428 HYPOXIA 13 0.0004
429 NECROSIS 2 0.0004
430 LUNG CONSOLIDATION 1 0.0004
431 ANAL HAEMORRHAGE 1 0.0004
432 CANDIDA INFECTION 6 0.0004
433 NECK MASS 1 0.0004
434 DEATH 304 0.0004
435 INJECTION SITE SCAR 1 0.0004
436 PSEUDOMONAS INFECTION 3 0.0003
437 PHARYNGEAL DISORDER 1 0.0003
438 LUNG CANCER METASTATIC 1 0.0003
439 PLEURAL EFFUSION 21 0.0003
440 ESCHERICHIA SEPSIS 1 0.0003
441 METABOLIC DISORDER 2 0.0003
442 LUNG INFILTRATION 3 0.0003
443 PERITONITIS 7 0.0003
444 PLEURISY 2 0.0003
445 NO ADVERSE EVENT 61 0.0003
446 THYROIDITIS 1 0.0003
447 LUNG ADENOCARCINOMA 1 0.0003
448 RECTAL CANCER 1 0.0003
449 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
450 UROSEPSIS 3 0.0003
451 DEVICE RELATED INFECTION 5 0.0003
452 AGRANULOCYTOSIS 6 0.0003
453 SQUAMOUS CELL CARCINOMA 3 0.0003
454 NON-CARDIAC CHEST PAIN 1 0.0003
455 PNEUMONIA 102 0.0003
456 LIVER ABSCESS 1 0.0003
457 AUTOIMMUNE DISORDER 3 0.0003
458 HYPOVENTILATION 1 0.0003
459 ASPERGILLUS INFECTION 2 0.0003
460 SARS-COV-2 TEST POSITIVE 4 0.0003
461 NEPHRITIS 1 0.0003
462 METASTASES TO SPINE 1 0.0003
463 BRONCHIECTASIS 2 0.0003
464 NEOPLASM RECURRENCE 1 0.0003
465 HEPATIC CYST 1 0.0003
466 BODY TEMPERATURE INCREASED 6 0.0003
467 SUDDEN CARDIAC DEATH 1 0.0003
468 NEUTROPHIL COUNT INCREASED 3 0.0003
469 ATRIAL FIBRILLATION 28 0.0003
470 INFUSION RELATED REACTION 19 0.0003
471 LOGORRHOEA 1 0.0003
472 FIBRIN D DIMER INCREASED 1 0.0003
473 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
474 ABDOMINAL PAIN LOWER 7 0.0003
475 BLOOD CREATININE INCREASED 18 0.0003
476 MONOCYTE COUNT INCREASED 1 0.0003
477 BLOOD PHOSPHORUS DECREASED 1 0.0003
478 DRUG RESISTANCE 7 0.0003
479 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
480 AMYLASE INCREASED 1 0.0003
481 BLOOD PRESSURE DECREASED 18 0.0003
482 TRANSAMINASES INCREASED 6 0.0003
483 RASH MACULO-PAPULAR 6 0.0003
484 RESPIRATORY TRACT INFECTION 7 0.0003
485 SKIN INFECTION 3 0.0003
486 OXYGEN SATURATION DECREASED 15 0.0003
487 PROTEIN TOTAL DECREASED 1 0.0003
488 HYPOCALCAEMIA 5 0.0003
489 TROPONIN INCREASED 2 0.0003
490 HERPES ZOSTER 15 0.0003
491 HAEMOLYSIS 2 0.0003
492 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
493 CARDIOPULMONARY FAILURE 1 0.0003
494 SPLENOMEGALY 3 0.0003
495 ORAL INFECTION 1 0.0003
496 HAEMATOCRIT DECREASED 5 0.0003
497 INFLAMMATION 13 0.0003
498 RENAL CYST 2 0.0003
499 BLOOD DISORDER 2 0.0002
500 INTERSTITIAL LUNG DISEASE 12 0.0002
501 PRODUCT ADMINISTRATION ERROR 5 0.0002
502 SHOCK HAEMORRHAGIC 2 0.0002
503 INTERCEPTED PRODUCT PREPARATION ERROR 3 0.0002
504 HYPERURICAEMIA 1 0.0002
505 EXTRAVASATION 1 0.0002
506 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
507 GASTROINTESTINAL PERFORATION 1 0.0002
508 BRAIN OEDEMA 3 0.0002
509 BUNDLE BRANCH BLOCK LEFT 1 0.0002
510 FEBRILE BONE MARROW APLASIA 1 0.0002
511 FACIAL PARALYSIS 2 0.0002
512 PULMONARY TUBERCULOSIS 1 0.0002
513 PYELONEPHRITIS 2 0.0002
514 FAECES DISCOLOURED 5 0.0002
515 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
516 URINE OUTPUT DECREASED 2 0.0002
517 DIVERTICULUM INTESTINAL 1 0.0002
518 PULMONARY FUNCTION TEST DECREASED 1 0.0002
519 BEDRIDDEN 3 0.0002
520 DISORIENTATION 9 0.0002
521 ABDOMINAL ABSCESS 1 0.0002
522 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
523 LIVER DISORDER 10 0.0002
524 NERVOUS SYSTEM DISORDER 7 0.0002
525 CARDIAC FAILURE 18 0.0002
526 GASTROINTESTINAL INFECTION 2 0.0002
527 MENINGITIS ASEPTIC 1 0.0002
528 IRON DEFICIENCY 1 0.0002
529 NEUROPATHY PERIPHERAL 21 0.0002
530 HYPOTENSION 44 0.0002
531 MOVEMENT DISORDER 7 0.0002
532 HYPOKALAEMIA 10 0.0002
533 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
534 ARTHRITIS INFECTIVE 1 0.0002
535 PERFORMANCE STATUS DECREASED 1 0.0002
536 APPENDICITIS 2 0.0002
537 ILL-DEFINED DISORDER 13 0.0002
538 BLOOD TEST ABNORMAL 3 0.0002
539 BLOOD SODIUM DECREASED 4 0.0002
540 LEUKAEMIA 2 0.0002
541 ACUTE KIDNEY INJURY 32 0.0002
542 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
543 HYPOVOLAEMIC SHOCK 1 0.0002
544 NON-SMALL CELL LUNG CANCER 1 0.0002
545 CHOLESTASIS 4 0.0002
546 GUILLAIN-BARRE SYNDROME 1 0.0002
547 ACUTE MYOCARDIAL INFARCTION 6 0.0002
548 CARDIOMYOPATHY 3 0.0002
549 STAPHYLOCOCCAL SEPSIS 1 0.0002
550 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
551 HYPERNATRAEMIA 1 0.0002
552 HAEMORRHAGE INTRACRANIAL 3 0.0002
553 KLEBSIELLA INFECTION 1 0.0002
554 HYPOTHERMIA 2 0.0002
555 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
556 HAEMATEMESIS 5 0.0002
557 PATHOLOGICAL FRACTURE 1 0.0002
558 CHILLS 23 0.0002
559 CACHEXIA 1 0.0002
560 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
561 PARTIAL SEIZURES 1 0.0002
562 HEPATIC ENZYME INCREASED 13 0.0002
563 CATATONIA 1 0.0002
564 ANAL FISSURE 1 0.0002
565 LIVER FUNCTION TEST INCREASED 4 0.0002
566 ANAL ABSCESS 1 0.0002
567 DECREASED ACTIVITY 2 0.0002
568 DEEP VEIN THROMBOSIS 12 0.0002
569 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
570 NONSPECIFIC REACTION 1 0.0002
571 STREPTOCOCCAL INFECTION 1 0.0002
572 NEPHROPATHY TOXIC 2 0.0002
573 ACUTE PULMONARY OEDEMA 1 0.0002
574 CHOLECYSTITIS ACUTE 1 0.0002
575 MYOCARDIAL ISCHAEMIA 2 0.0002
576 HAEMOGLOBIN DECREASED 18 0.0002
577 HAEMATURIA 6 0.0002
578 CARDIAC VALVE DISEASE 1 0.0002
579 NEUROLOGICAL SYMPTOM 1 0.0002
580 HYPERTONIA 1 0.0002
581 HERPES VIRUS INFECTION 1 0.0002
582 PERICARDIAL EFFUSION 4 0.0002
583 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
584 ELECTROLYTE IMBALANCE 2 0.0002
585 EYELID OEDEMA 2 0.0002
586 SKIN WARM 1 0.0002
587 VASCULITIS 2 0.0002
588 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
589 HYPERTRIGLYCERIDAEMIA 1 0.0002
590 DRUG ERUPTION 3 0.0002
591 CHOLECYSTITIS 2 0.0002
592 CEREBRAL HAEMORRHAGE 6 0.0002
593 PROTHROMBIN TIME PROLONGED 1 0.0002
594 BLOOD POTASSIUM DECREASED 5 0.0002
595 HEPATIC FAILURE 5 0.0002
596 LEUKOCYTOSIS 3 0.0002
597 APHASIA 5 0.0002
598 LIVER INJURY 4 0.0002
599 GENERALISED OEDEMA 2 0.0002
600 CHOLANGITIS 1 0.0002
601 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
602 TOOTH EXTRACTION 2 0.0002
603 PEMPHIGUS 2 0.0002
604 PRODUCT USE ISSUE 30 0.0002
605 COLITIS 6 0.0002
606 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
607 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
608 RENAL IMPAIRMENT 13 0.0002
609 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
610 ORAL CANDIDIASIS 2 0.0002
611 DYSGRAPHIA 1 0.0002
612 PANCREATITIS 8 0.0002
613 CORONAVIRUS INFECTION 1 0.0002
614 SKIN MASS 1 0.0001
615 MENINGITIS 1 0.0001
616 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
617 MALIGNANT MELANOMA 2 0.0001
618 FEEDING DISORDER 3 0.0001
619 UVEITIS 2 0.0001
620 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
621 ACUTE HEPATIC FAILURE 2 0.0001
622 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
623 AUTOIMMUNE HEPATITIS 1 0.0001
624 PAPULE 1 0.0001
625 BRONCHOSPASM 2 0.0001
626 RED BLOOD CELL COUNT DECREASED 4 0.0001
627 UNDERDOSE 10 0.0001
628 ASCITES 4 0.0001
629 HEPATOTOXICITY 3 0.0001
630 RENAL INJURY 4 0.0001
631 INFLUENZA 15 0.0001
632 PULMONARY MASS 2 0.0001
633 HEPATOCELLULAR CARCINOMA 1 0.0001
634 HAEMODYNAMIC INSTABILITY 1 0.0001
635 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
636 EJECTION FRACTION DECREASED 2 0.0001
637 PULMONARY HAEMORRHAGE 1 0.0001
638 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
639 PULMONARY EMBOLISM 12 0.0001
640 BLOOD ALBUMIN DECREASED 1 0.0001
641 ULCER 2 0.0001
642 ATRIAL FLUTTER 1 0.0001
643 BACK PAIN 29 0.0001
644 HYPERHIDROSIS 16 0.0001
645 POST PROCEDURAL INFECTION 1 0.0001
646 LUNG DISORDER 6 0.0001
647 ABNORMAL FAECES 1 0.0001
648 HICCUPS 1 0.0001
649 ESCHERICHIA INFECTION 1 0.0001
650 STAPHYLOCOCCAL INFECTION 4 0.0001
651 CARDIAC ARREST 10 0.0001
652 VENTRICULAR TACHYCARDIA 2 0.0001
653 ACUTE CORONARY SYNDROME 1 0.0001
654 COAGULOPATHY 2 0.0001
655 FACE OEDEMA 2 0.0001
656 HEMIPARESIS 2 0.0001
657 SKIN HYPERPIGMENTATION 1 0.0001
658 ANURIA 1 0.0001
659 MYOPATHY 1 0.0001
660 DEAFNESS 3 0.0001
661 EOSINOPHILIA 2 0.0001
662 BLOOD CALCIUM INCREASED 1 0.0001
663 GROIN PAIN 1 0.0001
664 GRIP STRENGTH DECREASED 1 0.0001
665 PURPURA 1 0.0001
666 RESPIRATORY RATE INCREASED 1 0.0001
667 GASTROINTESTINAL DISORDER 10 0.0001
668 URINARY TRACT INFECTION 19 0.0001
669 CONFUSIONAL STATE 18 0.0001
670 BRAIN NEOPLASM 1 0.0001
671 ARTERIOSCLEROSIS 1 0.0001
672 ARRHYTHMIA 5 0.0001
673 RENAL FAILURE 14 0.0001
674 GASTRIC ULCER 2 0.0001
675 PRODUCTIVE COUGH 5 0.0001
676 PULMONARY FIBROSIS 2 0.0001
677 SINUS BRADYCARDIA 1 0.0001
678 LIVER FUNCTION TEST ABNORMAL 3 0.0001
679 THROMBOTIC MICROANGIOPATHY 1 0.0001
680 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
681 VITREOUS FLOATERS 1 0.0001
682 PSYCHOTIC DISORDER 3 0.0001
683 HOSPICE CARE 1 0.0001
684 RESPIRATORY DISORDER 3 0.0001
685 HYPOTONIA 1 0.0001
686 EMPHYSEMA 1 0.0001
687 PERITONITIS BACTERIAL 1 0.0001
688 ABDOMINAL PAIN 23 0.0001
689 EYELID PTOSIS 1 0.0001
690 PRODUCT PREPARATION ERROR 2 0.0001
691 SPEECH DISORDER 5 0.0001
692 SUDDEN DEATH 1 0.0001
693 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
694 EATING DISORDER 2 0.0001
695 OVERDOSE 20 0.0001
696 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
697 CHOLELITHIASIS 3 0.0001
698 PRODUCT STORAGE ERROR 8 0.0001
699 WOUND INFECTION 1 0.0001
700 MELAENA 2 0.0001
701 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
702 OEDEMA PERIPHERAL 11 0.0001
703 VENTRICULAR FIBRILLATION 1 0.0001
704 STEVENS-JOHNSON SYNDROME 2 0.0001
705 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
706 OCULAR DISCOMFORT 1 0.0001
707 BLOOD CALCIUM DECREASED 1 0.0001
708 EYE INFECTION 1 0.0001
709 STATUS EPILEPTICUS 1 0.0001
710 REBOUND EFFECT 1 0.0001
711 MITRAL VALVE INCOMPETENCE 1 0.0001
712 MUSCULAR WEAKNESS 10 0.0001
713 IMPAIRED DRIVING ABILITY 1 0.0001
714 DELIRIUM 3 0.0001
715 HYPERKALAEMIA 3 0.0001
716 DISEASE RECURRENCE 4 0.0001
717 DRUG INTOLERANCE 8 0.0001
718 THERAPEUTIC RESPONSE DECREASED 5 0.0001
719 HYPERGLYCAEMIA 3 0.0001
720 CEREBRAL INFARCTION 2 0.0001
721 DECREASED APPETITE 19 0.0001
722 HEART RATE INCREASED 8 0.0001
723 ASTHENIA 30 0.0001
724 INTESTINAL OBSTRUCTION 3 0.0001
725 MUSCLE ATROPHY 1 0.0001
726 TACHYCARDIA 7 0.0001
727 CARDIOVASCULAR DISORDER 2 0.0001
728 COUGH 22 0.0001
729 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
730 MYDRIASIS 1 0.0001
731 DIPLOPIA 2 0.0001
732 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
733 MUSCULOSKELETAL PAIN 4 0.0001
734 CORONARY ARTERY OCCLUSION 1 0.0001
735 INFLUENZA LIKE ILLNESS 6 0.0001
736 DRUG INEFFECTIVE 96 0.0001
737 PERIPHERAL COLDNESS 1 0.0001
738 HAEMATOCHEZIA 4 0.0001
739 FEELING COLD 2 0.0001
740 HYPOMAGNESAEMIA 1 0.0001
741 CARDIO-RESPIRATORY ARREST 3 0.0001
742 APHONIA 1 0.0001
743 DEVICE OCCLUSION 1 0.0001
744 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
745 HYPONATRAEMIA 4 0.0001
746 PARALYSIS 1 0.0001
747 DYSSTASIA 2 0.0001
748 SINUSITIS 7 0.0001
749 ERYTHEMA 14 0.0001
750 VOMITING 32 0.0001
751 LABORATORY TEST ABNORMAL 2 0.0001
752 BRONCHITIS 5 0.0001
753 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
754 OESOPHAGEAL CARCINOMA 2 0.0001
755 RASH 29 0.0001
756 HYPOAESTHESIA ORAL 1 0.0001
757 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
758 EPILEPSY 2 0.0001
759 NEPHROLITHIASIS 3 0.0001
760 SWELLING 6 0.0001
761 BASAL CELL CARCINOMA 1 0.0001
762 DRUG-INDUCED LIVER INJURY 2 0.0001
763 DIARRHOEA 41 0.0001
764 NIGHT SWEATS 2 0.0001
765 BLOOD POTASSIUM INCREASED 1 0.0001
766 SEIZURE 7 0.0001
767 EXPIRED PRODUCT ADMINISTERED 2 0.0001
768 CELLULITIS 3 0.0001
769 CIRCULATORY COLLAPSE 1 0.0001
770 ORTHOSTATIC HYPOTENSION 1 0.0001
771 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
772 ISCHAEMIC STROKE 1 0.0001
773 GOUT 1 0.0001
774 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
775 SYNOVITIS 1 0.0001
776 OSTEOMYELITIS 1 0.0001
777 PELVIC PAIN 1 0.0001
778 HEPATIC STEATOSIS 1 0.0001
779 CARDIAC DISORDER 5 0.0001
780 HEPATIC CIRRHOSIS 1 0.0001
781 DYSARTHRIA 2 0.0001
782 CONDITION AGGRAVATED 16 0.0001
783 ACUTE RESPIRATORY FAILURE 1 0.0001
784 HYPERTENSION 11 0.0001
785 PRESCRIBED OVERDOSE 1 0.0001
786 EAR PAIN 1 0.0001
787 HAEMORRHOIDS 1 0.0001
788 ORAL HERPES 1 0.0001
789 BONE PAIN 3 0.0001
790 PARAESTHESIA 8 0.0001
791 PAIN 31 0.0001
792 BLOOD PRESSURE ABNORMAL 1 0.0001
793 FULL BLOOD COUNT DECREASED 1 0.0000
794 TASTE DISORDER 1 0.0000
795 BONE MARROW FAILURE 1 0.0000
796 DISCOMFORT 3 0.0000
797 BLINDNESS 2 0.0000
798 INJECTION SITE WARMTH 1 0.0000
799 HAEMORRHAGE 5 0.0000
800 MOUTH ULCERATION 1 0.0000
801 SKIN CANCER 1 0.0000
802 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
803 DYSPNOEA 26 0.0000
804 PRODUCT DISPENSING ERROR 1 0.0000
805 PRODUCT PRESCRIBING ISSUE 1 0.0000
806 ORAL PAIN 1 0.0000
807 PANCREATITIS ACUTE 1 0.0000
808 RENAL DISORDER 2 0.0000
809 HEPATIC CANCER 1 0.0000
810 HYPOGLYCAEMIA 2 0.0000
811 PRESYNCOPE 1 0.0000
812 NEURALGIA 1 0.0000
813 AGITATION 3 0.0000
814 ENCEPHALOPATHY 1 0.0000
815 EPISTAXIS 3 0.0000
816 PNEUMONIA ASPIRATION 1 0.0000
817 HEADACHE 25 0.0000
818 FATIGUE 31 0.0000
819 HEPATITIS 1 0.0000
820 CHEST DISCOMFORT 4 0.0000
821 ERECTILE DYSFUNCTION 1 0.0000
822 SKIN ULCER 1 0.0000
823 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
824 OEDEMA 2 0.0000
825 LIMB INJURY 1 0.0000
826 NAUSEA 29 0.0000
827 SKIN LESION 1 0.0000
828 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
829 RESPIRATORY DISTRESS 1 0.0000
830 TREATMENT FAILURE 3 0.0000
831 DIVERTICULITIS 1 0.0000
832 HAEMOPTYSIS 1 0.0000
833 SOMNOLENCE 7 0.0000
834 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
835 PRURITUS 13 0.0000
836 URINARY INCONTINENCE 1 0.0000
837 CATARACT 2 0.0000
838 IRRITABILITY 2 0.0000
839 NASOPHARYNGITIS 6 0.0000
840 SWOLLEN TONGUE 1 0.0000
841 CYSTITIS 1 0.0000
842 METABOLIC ACIDOSIS 1 0.0000
843 HIP FRACTURE 1 0.0000
844 VISUAL ACUITY REDUCED 1 0.0000
845 SYNCOPE 3 0.0000
846 GAIT INABILITY 1 0.0000
847 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
848 CEREBROVASCULAR ACCIDENT 5 0.0000
849 MYALGIA 5 0.0000
850 ABDOMINAL PAIN UPPER 6 0.0000
851 DEVICE USE ERROR 1 0.0000
852 RASH MACULAR 1 0.0000
853 THERAPY INTERRUPTED 2 0.0000
854 MUSCLE SPASMS 5 0.0000
855 DYSURIA 1 0.0000
856 DEVICE BREAKAGE 1 0.0000
857 DYSKINESIA 1 0.0000
858 COMPLETED SUICIDE 2 0.0000
859 MENTAL DISORDER 1 0.0000
860 CONSTIPATION 5 0.0000
861 MALAISE 10 0.0000
862 PULMONARY OEDEMA 1 0.0000
863 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
864 MEMORY IMPAIRMENT 3 0.0000
865 OROPHARYNGEAL PAIN 2 0.0000
866 BLOOD CHOLESTEROL INCREASED 1 0.0000
867 OCULAR HYPERAEMIA 1 0.0000
868 FALL 7 0.0000
869 COMA 1 0.0000
870 BLOOD GLUCOSE DECREASED 1 0.0000
871 DYSPEPSIA 2 0.0000
872 HYPOAESTHESIA 3 0.0000
873 AGGRESSION 1 0.0000
874 FLUSHING 2 0.0000
875 BLOOD PRESSURE INCREASED 3 0.0000
876 THERAPY CESSATION 1 0.0000
877 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
878 TREMOR 3 0.0000
879 MEDICATION ERROR 1 0.0000
880 NECK PAIN 1 0.0000
881 TOXICITY TO VARIOUS AGENTS 3 0.0000
882 LETHARGY 1 0.0000
883 MYOCARDIAL INFARCTION 3 0.0000
884 WHEEZING 1 0.0000
885 ARTHRALGIA 7 0.0000
886 VERTIGO 1 0.0000
887 HYPERSENSITIVITY 3 0.0000
888 SWELLING FACE 1 0.0000
889 INSOMNIA 4 0.0000
890 NEOPLASM MALIGNANT 1 0.0000
891 INJECTION SITE REACTION 1 0.0000
892 WEIGHT DECREASED 4 0.0000
893 SLEEP DISORDER 1 0.0000
894 DIZZINESS 7 0.0000
895 MOBILITY DECREASED 1 0.0000
896 PAIN IN EXTREMITY 4 0.0000
897 DYSGEUSIA 1 0.0000
898 HALLUCINATION 1 0.0000
899 CHRONIC KIDNEY DISEASE 1 0.0000
900 PERIPHERAL SWELLING 2 0.0000
901 ARTHRITIS 1 0.0000
902 FEELING ABNORMAL 3 0.0000
903 THROMBOSIS 1 0.0000
904 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
905 URTICARIA 2 0.0000
906 BALANCE DISORDER 1 0.0000
907 INTENTIONAL PRODUCT MISUSE 1 0.0000
908 ADVERSE DRUG REACTION 1 0.0000
909 BREAST CANCER 1 0.0000
910 DYSPHAGIA 1 0.0000
911 CONTUSION 1 0.0000
912 PRODUCT DOSE OMISSION ISSUE 3 0.0000
913 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
914 ILLNESS 1 0.0000
915 ABDOMINAL DISTENSION 1 0.0000
916 WEIGHT INCREASED 2 0.0000
917 INCORRECT DOSE ADMINISTERED 2 0.0000
918 PALPITATIONS 1 0.0000
919 VISUAL IMPAIRMENT 1 0.0000
920 INJECTION SITE ERYTHEMA 1 0.0000
921 LOSS OF CONSCIOUSNESS 1 0.0000
922 PSORIASIS 1 0.0000
923 DEHYDRATION 1 0.0000
924 VISION BLURRED 1 0.0000
925 DRUG INTERACTION 1 0.0000
926 ABDOMINAL DISCOMFORT 1 0.0000
927 CHEST PAIN 1 0.0000
928 BLOOD GLUCOSE INCREASED 1 0.0000
929 GAIT DISTURBANCE 1 0.0000
930 DEPRESSION 1 0.0000
931 ANXIETY 1 0.0000